The synthesis of Bcl-2 and other proteins in the neoplastic follicles of follicular lymphoma

Journal of Clinical Pathology - Molecular Pathology

Volumn 52, Issue 1, 1999, Pages 29-31

  Lampert, I A ^a  

^a EALING HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; CD45 ANTIGEN; DNA; MESSENGER RNA; PROTEIN BCL 2;

B CELL LYMPHOMA; B LYMPHOCYTE; CHROMOSOME 18; CHROMOSOME TRANSLOCATION 14; FOLLICULAR LYMPHOMA; GERMINAL CENTER; HUMAN; LYMPH FOLLICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTO ONCOGENE; REVIEW;

EID: 0032896454     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.52.1.29     Document Type: Review

References (24)

1. 1 Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl2/immunoglobulin transcript resulting from the t(14,18) translocation. Cell 1986;10;47:19-28.
2. 2 McDonnell TJ, Deane N, Platt FM, et al. bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989; 57:79-88.
3. 3 McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(t4;18). Nature 1991;349:254-6.
4. 4 MacLennan IC, Gray D. Antigen-driven selection of virgin and memory B cells. Immunol Rev 1986;91:61-85.
5. 5 Hockenbery DM, Zutter M, Hickey W, et al. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991;88: 6961-5.
6. 6 Harris NL, Jaffe ES, Stein H, et al. A revised European American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84:1361-92.
7. 7 Pezella F, Gatter KC, Mason DY, et al. bcl-2 protein expression in follicular lymphomas in the absence of 14;18 translocation. Lancet 1990;336:1510-1.
8. 8 Caligaris-Cappio F, Gottardi D, Alfarano A, et al. The nature of the B lymphocyte in B-chronic lymphocytic leukemia. Blood Cells 1993;19:601-13.
9. 9 Gaulard P, d'Agay MF, Peuchmaur M, et al. Expression of the bcl-2 gene product in follicular lymphoma. Am J Pathol 1992;140:1089-95.
10. 10 Kondo E, Nakamura S, Onoue H, at al. Detection of bcl-2 protein and bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization. Blood 1992;80:2044-51.
11. 11 Chleq-Deschamps CM, LeBrun DP, Huie P, et al. Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues. Blood 1993; 81:293-8.
12. 12 Akagi T, Kondo E, Yoshino T. Expression of Bcl-2 protein and Bcl-2 mRNA in normal and neoplastic lymphoid tissues. Leuk Lymphoma 1994;13:81-7.
13. 13 Pilkington GS, Rockman J, Quirk S, et al. Association of phenotype determined using monoclonal antibodies CD1-CD24 with histologic classification and karyotype in 180 non-Hodgkin's lymphomas. In: McMichael AJ, Beverley PCL, Cobbold S, et al., eds. Leucocyte typing III white cell differentiation antigens. Oxford: Oxford University Press, 1987:454-61.
14. 14 Paramithiotis E, Cooper MD. Memory B lymphocytes migrate to bone marrow in humans. Proc Natl Acad Sci USA 1997;94:208-12.
15. 15 Kremmidiotis G, Zola H. Changes in CD44 expression during B cell differentiation in the human tonsils. Cell Immunol 1995;161;147-57.
16. 16 Schmid U, Cogliatti SB, Diss TC, et al. Monocytoid/marginal zone B-cell differentiation in follicle centre cell lymphoma. Histopathology 1996;29:201-8.
17. 17 Alkan S, Ross CW, Hanson CA, et al. Follicular lymphoma with involvement of the splenic marginal zone: a pitfall in the differential diagnosis of splenic marginal zone cell lymphoma. Hum Pathol 1996;27:503-6.
18. 18 Galibert L, Burdin N, de Saint-Vis B, et al. CD40 and B cell antigen receptor dual triggering of resting lymphocytes turns on a partial germinal center phenotype. J Exp Med 1996;183:77-85.
19. 19 Grimaitre M, Werner-Favre C, Kindler V, et al. Human naive B cells cultured with EL-4 T cells mimic a germinal center-related B cell stage before generating plasma cells. Concordant changes in Bcl-2 protein and messenger RNA levels. Eur J Immunol 1997;27:199-205.
20. 20 Peters JPJ, Rademakers LEPM, De Boer RJ, et al. Cellular composition of follicles of follicle centre cell lymphomas in relation to germinal centres of reactive lymph nodes. A morphometrical electromicroscopical study. J Pathol 1987; 153:233-44.
21. 21 Alavaikko M, Aine R, Rinne A, et al. Behaviour of dendritic reticulum cells possessing immunoreactive acid cysteine proteinase inhibitor in human lymphoid secondary follicles and in follicular-centre cell lymphomas. Int J Cancer 1985; 35:319-25.
22. 22 Lampert IA, Van Norden S. Acetyl cholinesterase is expressed in the follicular dendritic cells of germinal centres: differences between normal and neoplastic follicles. J Pathol 1996;180:169-74.
23. 23 Stein H, Gerdes J, Mason DY. The normal and malignant germinal centre. Clin Haematol 1992;11:531-58.
24. 24 Cibill ML, Heryet K, Gatter KC, et al. The utility of Ki67 immunostaining, nuclear organizer region counting and morphology of follicular lymphomas. J Pathol 1989;158: 189-93.